Delineating the mechanism of amyloid beta toxicity

Grant number: 1049167 | Funding period: 2013 - 2016



Alzheimer’s disease and beta amyloid toxicity: Alzheimer’s disease (AD) is the most common form of dementia and is characterized by progressive memory loss, confusion, and cognitive deficits. In 2011, an estimated 269,000 Australians are currently living with dementia and without a significant medical breakthrough soon, it is anticipated that this will rise to about 981,000 by 2050

University of Melbourne Researchers